| 产品详情 |
| Edit |   |
| Antigenic Specificity | CD158b (KIR2DL2/L3, NKAT2) |
| Clone | DX27 |
| Host Species | Mouse |
| Reactive Species | human |
| Isotype | IgG2a, κ |
| Format | PE-Cy7 conjugate |
| Size | 100 tests |
| Concentration | n/a |
| Applications | Flow Cytometry (FC) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | PE/Cy7 anti-human CD158b (KIR2DL2/L3, NKAT2). CD158b is expressed on natural killer cells and a subset of T cells. It is a member of the immunoglobulin superfamily containing two immunoglobulin C2-type domains. Both variants and alternative isoforms of CD158b have been reported. The interaction of CD158b with specific HLA-C antigens on a target cell (HLA-Cw1, HLA-Cw3, HLA-Cw7 alleles, for example) inhibits cytotoxicity and prevents target cell lysis and death. The interactions between KIR and MHC class I are thought to be important in NK cell and T cell regulation following antigen stimulation. The absence of ligands for KIRs may lower the threshold for activation through activating receptors and increase inflammation and susceptibility to autoimmune disease. |
| Immunogen | n/a |
| Other Names | CD158b1 (KIR2DL2, p58.2), CD158b2 (KIR2DL3, p58.3), CD158j (KIR2DS2, p50.2), KIR-NKAT2 |
| Gene, Accession # | Gene ID: 3803 |
| Catalog # | 312610 |
| Price | |
| Order / More Info | CD158b (KIR2DL2/L3, NKAT2) Antibody from BIOLEGEND |
| Product Specific References | n/a |
| 产品资料 |
|
|